Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.


Known as: 3-(5-(4,5-dihydro-1H-imidazol-2-yl)furan-2-yl)phenylamine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
On the basis of the observation that the central side effects of MAO inhibitors may represent a major limit for their use in… Expand
Is this relevant?